相关实验视频

Updated: Jun 6, 2025

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer
08:29

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer

Published on: November 1, 2019

7.0K

是否26S蛋白酶非ATPase调节子单元6是肝内胆固醇癌的潜在分子标?

Yong-Zhi Zhuang1, Li-Quan Tong2, Xue-Ying Sun3,4

  • 1Department of Oncology, The Fifth Affiliated Hospital of Harbin Medical University, Daqing 163316, Heilongjiang Province, China.

World journal of hepatology
|November 28, 2024
PubMed
概括

26S蛋白酶组调节子单元6 (PSMD6) 对于肝脏内胆瘤 (iCCA) 细胞增殖至关重要. 虽然PSMD6在iCCA组织中过度表达,但需要进一步的研究来确认PSMD6是这种具有挑战性的癌症的治疗标.

关键词:
26S蛋白质酶非ATPase调节子单元6胆性瘤是一种胆性瘤.聚类有规律间隔的短palindromic重复.分子向疗法 分子向疗法蛋白质酶体抑制剂 蛋白质酶体抑制剂

更多相关视频

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

759
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.8K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K